Limm Therapeutics

Providers of therapeutics based on neuronal and innate lymphoid cells

placeParis, Ile De France, France calendar_todayFounded 2019 groups8 employees language limmtx.com

Innovation

1 patent family — focus: Human necessities; filing pace dormant. Cited 2 times.

YearFilings
20181
20191

Investor mix

6 investors on record; lead investors include Seventure Partners, 200M.

Investor typeCountShare
Venture capital583%
Accelerator & incubator117%
Coming soon